Atovaquone proguanil hydrochloride: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{XXXXX}} {{CMG}} ==Overview== ==Category== ==US Brand Names== MALARONE<sup>®</sup> ==FDA Package Insert== ''' Description''' '''| XXXX..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Atovaquone proguanil hydrochloride}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Overview== | ==Overview== | ||
| Line 10: | Line 10: | ||
MALARONE<sup>®</sup> | MALARONE<sup>®</sup> | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
[[Image:WikEd_bold.png|16px|Bold]] | |||
''' [[ | ''' [[Atovaquone proguanil hydrochloride description|Description]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride microbiology|Microbiology]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride how supplied|How Supplied]]''' | ||
'''| [[ | '''| [[Atovaquone proguanil hydrochloride labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Latest revision as of 18:04, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Category
US Brand Names
MALARONE®
FDA Package Insert
Bold Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages
